Susquehanna International Group, LLP United Therapeutics Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $8.71 Million - $10.2 Million	-28,000 Reduced 22.99%	93,800 $33.6 Million
Q2 2024 Aug 15, 2024	BUY	$228.26 - $319.04 $11.8 Million - $16.6 Million	51,900 Added 74.25%	121,800 $38.8 Million
Q1 2024 May 07, 2024	BUY	$210.76 - $249.51 $5.1 Million - $6.04 Million	24,200 Added 52.95%	69,900 $16.1 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $666,128 - $796,514	-3,100 Reduced 6.35%	45,700 $10 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $1.14 Million - $1.34 Million	-5,400 Reduced 9.96%	48,800 $11 Million
Q2 2023 Aug 11, 2023	SELL	$205.19 - $232.99 $2.3 Million - $2.61 Million	-11,200 Reduced 17.13%	54,200 $12 Million
Q1 2023 May 16, 2023	BUY	$212.99 - $276.17 $3.73 Million - $4.83 Million	17,500 Added 36.53%	65,400 $14.6 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $8.05 Million - $11 Million	-39,100 Reduced 44.94%	47,900 $13.3 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $11.7 Million - $14 Million	-57,500 Reduced 39.79%	87,000 $18.2 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $14.2 Million - $19.7 Million	81,500 Added 129.37%	144,500 $34.1 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $880,648 - $1.13 Million	5,300 Added 9.19%	63,000 $11.3 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $184,320 - $216,080	-1,000 Reduced 1.7%	57,700 $12.5 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $197,846 - $236,368	-1,100 Reduced 1.84%	58,700 $10.8 Million
Q2 2021 Aug 11, 2021	BUY	$170.47 - $211.93 $2.73 Million - $3.39 Million	16,000 Added 36.53%	59,800 $10.7 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $5.83 Million - $6.63 Million	37,900 Added 642.37%	43,800 $7.33 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $631,594 - $941,098	-6,200 Reduced 51.24%	5,900 $896,000
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $3.58 Million - $4.34 Million	-35,800 Reduced 74.74%	12,100 $1.22 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $1.6 Million - $2.18 Million	-17,300 Reduced 26.53%	47,900 $5.8 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $770,083 - $1.12 Million	9,700 Added 17.48%	65,200 $6.18 Million
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $1.1 Million - $1.33 Million	14,000 Added 33.73%	55,500 $4.89 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $44,910 - $51,594	-600 Reduced 1.43%	41,500 $3.31 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $3.53 Million - $5.61 Million	-46,400 Reduced 52.43%	42,100 $3.29 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $6.79 Million - $8.04 Million	63,400 Added 252.59%	88,500 $10.4 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $5.33 Million - $6.77 Million	-52,600 Reduced 67.7%	25,100 $2.73 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $9.25 Million - $10.5 Million	-81,300 Reduced 51.13%	77,700 $9.94 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $11.6 Million - $13.6 Million	114,900 Added 260.54%	159,000 $18 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $1.34 Million - $1.9 Million	-12,500 Reduced 22.08%	44,100 $4.96 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $2.21 Million - $2.81 Million	-18,600 Reduced 24.73%	56,600 $8.37 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $8.62 Million - $10.3 Million	75,200	75,200 $8.81 Million

Others Institutions Holding UTHR

# of Institutions

672

Shares Held

42.4M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$1.96 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.58 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.13 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.02 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$800 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account